Yutiq (fluocinolone acetonide intravitreal implant) / EyePoint Pharma  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Yutiq (fluocinolone acetonide intravitreal implant) / EyePoint Pharma
NCT05070728: Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert (FAI)

Terminated
3
12
US
Sham Injector, Sham Comparator, FAI Insert, Active Drug
EyePoint Pharmaceuticals, Inc.
Uveitis, Uveitis, Posterior, Uveitis, Intermediate
10/22
04/23

Download Options